We are proud to announce the successful installation of the first eWitness electronic witnessing system in Greece at Embryolab Fertility Clinic in Thessaloniki.

This milestone reflects our ongoing commitment to bringing innovative technologies that enhance safety, quality, and efficiency in reproductive medicine. The implementation of eWitness marks an important advancement for the IVF sector in Greece, setting new standards for laboratory traceability and patient safety.

Developed by Vitrolife, part of Vitrolife Group, eWitness is an advanced electronic witnessing system designed to safeguard every stage of the IVF process. Utilizing RFID and barcode technology, the system continuously monitors, tracks, and verifies patient information and biological samples in real time, providing an additional layer of security throughout laboratory procedures.

Key Benefits of the eWitness System

Enhanced Patient Safety
Automated identity verification at critical stages of the IVF process helps minimize the risk of human error and strengthens laboratory quality assurance.

Complete Traceability
The system creates a comprehensive and permanent record of each treatment cycle, ensuring full transparency and accountability throughout the patient journey.

Optimized Laboratory Workflow
Seamlessly integrated into routine laboratory operations, eWitness supports embryologists in maintaining focus on their specialized work while enhancing operational efficiency.

We thank Embryolab Fertility Clinic for its trust and collaboration in adopting this pioneering technology. The successful implementation of Greece’s first eWitness system reflects a shared commitment to clinical excellence and continuous innovation in assisted reproduction.

For more than 30 years, our mission has been to bring world-leading medical technologies to healthcare professionals across Greece and Cyprus, supporting advancements that improve patient care and clinical outcomes.